PVA
Click for more information
0.00% $2.99 psivida corp.

1. Potential European approval for illuvien still possible...

  1. suhm
    1,185 Posts.
    lightbulb Created with Sketch. 75
    clock Created with Sketch.
    14/11/11
    20:53
    Post #: 9285306
    1. Potential European approval for illuvien still possible (possible)
    2. Illuvien for Uveitis (100% ownership) and retisert already approved on much worse data set. (possible)
    3. Illuvien for Glucoma. (It causes glaucoma, so wrong)
    4. 4th Generation Protein delivery system (possible)
    5. Collaboration and licensing deals for illuvien for other parts of the body. (maybe don't see an application for it)
    6. Biosilicone (long way from commercilisation)

    7. 21 mil in cash I will take your word for it haven't checked.
    PVA Price at posting: $2.10 Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
right-arrow Created with Sketch.
RHK Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit
right-arrow Created with Sketch.
MIN MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned
right-arrow Created with Sketch.
NEWS Real estate dynamics & changes raise investor doubt
right-arrow Created with Sketch.
MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PVA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.